Atossa Genetics announced the hiring of Jelle Kylstra as its new VP of clinical research and development. Kylstra joined the company on May 19, and brings with her more than 23 years of industry experience.
Before joining Atossa, Kylstra was VP of global clinical affairs at Spectrum Pharmaceuticals. Prior to that, Kylstra held various leadership roles at AngioDynamics, Light Sciences Corp., and other firms.
BioNano Genomics announced that Mike Ward will serve as its VP of corporate development. Ward brings to the company more than two decades of experience in life sciences-related investment banking, venture capital, and private equity.
Ward comes to BioNano from Lurie Investment Fund. He has worked at various investment banks, including Leerink Partners, Credit Suisse, and others.